KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Other Gross PP&E Adjustments (2016 - 2025)

Boston Scientific (BSX) has disclosed Other Gross PP&E Adjustments for 17 consecutive years, with $3.3 billion as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 6.05% to $3.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 billion through Dec 2025, up 6.05% year-over-year, with the annual reading at $3.3 billion for FY2025, 6.05% up from the prior year.
  • Other Gross PP&E Adjustments hit $3.3 billion in Q4 2025 for Boston Scientific, up from -$347.0 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.3 billion in Q4 2025 to a low of -$347.0 million in Q3 2025.
  • Historically, Other Gross PP&E Adjustments has averaged $55.1 million across 5 years, with a median of -$301.0 million in 2021.
  • Biggest five-year swings in Other Gross PP&E Adjustments: plummeted 63.35% in 2021 and later skyrocketed 1149.5% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at -$325.0 million in 2021, then increased by 23.69% to -$248.0 million in 2022, then decreased by 20.56% to -$299.0 million in 2023, then surged by 1149.5% to $3.1 billion in 2024, then rose by 6.05% to $3.3 billion in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for BSX at $3.3 billion in Q4 2025, -$347.0 million in Q3 2025, and -$345.0 million in Q2 2025.